
Genix Pharmaceuticals Corporation (GENPF)
GENPF Stock Price Chart
Explore Genix Pharmaceuticals Corporation interactive price chart. Choose custom timeframes to analyze GENPF price movements and trends.
GENPF Company Profile
Discover essential business fundamentals and corporate details for Genix Pharmaceuticals Corporation (GENPF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
18 Feb 2020
Employees
—
Website
https://www.genixpharm.comCEO
Sina Salehi Pirooz
Description
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
GENPF Financial Timeline
Browse a chronological timeline of Genix Pharmaceuticals Corporation corporate events including earnings releases, dividend announcements, and stock splits.
GENPF Stock Performance
Access detailed GENPF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.